Blackstone Group »

Effector Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Effector Therapeutics shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Effector Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Effector Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Effector Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0k 52k 0.04
2024-06-30 $15k 52k 0.29
2024-03-31 $753k 52k 14.39
2023-12-31 $612k 1.3M 0.47
2023-09-30 $785k 1.3M 0.60
2023-06-30 $1.1M 1.3M 0.83
2023-03-31 $462k 1.3M 0.35
2022-12-31 $560k 1.3M 0.43
2022-09-30 $749k 1.3M 0.57
2022-06-30 $1.9M 1.3M 1.42
2022-03-31 $5.2M 1.3M 4.01
2021-12-31 $7.8M 1.3M 5.96
2021-09-30 $18M 1.3M 14.05

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Energy Transfer Com Ut Ltd Ptn (ET)
Corebridge Finl (CRBG)
FirstEnergy (FE)
Chesapeake Energy Corp (CHK)
MPLX Com Unit Rep Ltd (MPLX)
Loar Holdings Com Shs (LOAR)
Targa Res Corp (TRGP)
Cheniere Energy Com New (LNG)
Western Midstream Partners L Com Unit Lp Int (WES)
Williams Companies (WMB)
Kinetik Holdings Com New Cl A (KNTK)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Enterprise Products Partners (EPD)
Gates Indl Corp Ord Shs (GTES)

View all positions for Blackstone Group

Top funds holding Effector Therapeutics

Blackstone Group

View all funds holding Effector Therapeutics